Author's reply
The authors respond to my recent letter! by incorrectly stating: 'Stockl criticizes the use of plots of difference against mean in the comparison of two methods of measurement, on the ground that they assume a constant standard deviation over the range of data. He recommends the use (J{ regression instead'.
The message of the article! was that merits and pitfalls of certain graphical presentations should not be mixed up with those of certain statistical techniques.
Amongst the graphical techniques that are available for method comparisons are xjy plots and plots of difference against mean. The x-axis of the latter can be constructed on the basis of the mean of two methods (when they are hierarchically equivalent) or by using the values measured by one method (the hierarchically higher method). The y-axis, on the other hand,
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can be constructed using the absolute paired differences of the methods or the percent paired differences of the methods. Among the statistical techniques available are the F-test, the t-test, calculation of limits of agreement, correlation analysis, and various forms of regression analysis (simple, weighted, Deming, non-parametric, general curve-fitting).
My position concerning recommendation of certain graphical or statistical techniques for method comparison studies is the following. Know them all, understand their strengths and weaknesses and apply them all to your problem. Select those graphical techniques that make your results most easily comprehensible for others, without compromising their scientific validity. Select those statistical techniques that are most appropriate to the facts you want to investigate. At that stage, carefully review whether your experimental approach was appropriate to the conclusions you want to draw (for example, enough samples, correct concentration range, adequate internal quality control, etc.).
In summary, I do not underestimate the weaknesses of certain graphical or statistical concepts and I support many of the arguments put forward by the authors in their letter. However, I would like to repeat the statement I made before; 1 that instead of scientific journals principally rejecting certain statistical or graphical techniques of method comparison, they should ensure that their reviewers check that the techniques adopted had been correctly applied. 
Age-related changes in albumin adjusted serum calcium in Hong Kong Chinese
We read with interest the papers by Payne and Barth which showed that 'albumin adjusted serum calcium' changed significantly with age in women but not in men.l-' We analysed serum calcium and albumin concentrations using data collected from 1484 subjects (905 men, 579 women) in a prevalence survey of diabetes 
Mean (SO) (range) ·P<O·OOI; ··P<O·OOI after adjusting for age Adjusted calcium = measured calcium-(0·0188 x albumin) + (2'41-1-4072) mellitus in Hong Kong Chinese.' Blood was taken after a 12-h fast. Serum albumin and calcium concentrations were determined by automated methods (Parellel! analyser, American Monitor Corp, Indiana, USA). The reference ranges for albumin and total calcium were 36-48 g/L and 2·20-2·62 mmol/L, respectively. All results are expressed as mean (SD).
The associations between variables were tested using Pearson's correlation coefficients. Student's r-test and analysis of covariate (AN CO-VA) with age adjustment were used for between groups comparison. A P-value of < 0·05 (2tailed) was considered to be significant. The least square regression coefficient of calcium on albumin was 0·0188 and the calcium intercept at zero albumin concentration was 104072. Using the method adopted by Barth et al.,2 the equation of adjusted calcium of our own hospital will then be:
adjusted calcium = measured calcium -(0,0 188 x albumin) + (2-41 -1-4072) In contrast to the findings reported by Payne and Barth, 1 the serum calcium and albumin Ann cu« Biochem 1997: 34 concentrations were different between men and women in our study (Table I ). There was no correlation between age and adjusted serum calcium in men (/"= -0·029, P=0'378) and women (/"=0'047, P=0·256). When the adjusted serum calcium concentrations were stratified by 10-year age groups, there was no difference in the adjusted serum calcium among different age groups in men. However, similar to the findings reported by Payne and Barth, 1 progressive increase in adjusted serum calcium was observed in women starting from the age of 30 years onward (Table 2) . Higher serum calcium was also found in younger women, less than 20 years old in Payne's subjects' and in our study, less than 30 years of age.
Higher albumin adjusted serum calcium (2,24 (0'0 I) mmol/L versus 2·16 (0,0 I) mrnol/L, P < 0'05) and parathyroid hormone (PTH) concentrations (2'99 (0'15) pmol/L versus 1·52 (0'08)pmol/L, P<O'OOOI) in Chinese women older than 60 years compared to those aged between 19-40 years had previously been reported." These findings may be related to the onset of menopause which is associated with relative increase in osteoclastic activity but reduced bone formation.t In this respect, the post-menopausal increase in serum ionized calcium concentrations has been shown to be reduced by replacement oestrogen treatment." Although serum PTH and post-menopausal status have not been examined in this study, it is noteworthy that the mean age of menopause is 51 in Asian women."
In conclusion, in our Hong Kong Chinese serum albumin and albumin adjusted serum calcium concentrations were higher in men than women. Similar to other studies,':" albumin adjusted serum calcium concentrations change with age in women but not in men. These agerelated differences may be related to menopause but the exact mechanism requires further elucidation. Maturitas 1994; 19: 205 Paradoxical high-density lipoprotein reduction induced by fibrate therapy
We were interested to read the case report by P 0 Collinson and colleagues, 1 since we have also encountered a patient whose high-density lipoprotein (HDL) cholesterol concentration decreased markedly following treatment with fibrate drugs. A 43-year-old man was referred to our lipid clinic in 1988 by his general practitioner with a mixed hyperlipidaemia (Table 1) . He smoked 20 cigarettes daily, had a family history of premature cardiovascular disease and was (and still is) taking benzodiazepine tranquillizers for anxiety.
He was given dietary advice, but did not attend for follow-up and was re-referred in 1992 with similar lipid concentrations. He was treated over the next 4 years with bezafibrate 200 mg three times a day. During 1994 he was prescribed ciprofibrate, 100 mg daily, which were stopped after 6 months because he developed muscle cramps, although his serum creatine kinase was normal. He was then prescribed acipimox 250 mg twice a day but again he stopped taking them, this time because they caused abdominal pain.
The HDL cholesterol concentration (see Table  1 ) decreased after 2 years of bezafibrate therapy and remained very low while he continued on fibrate therapy. However, it returned to normal on acipimox therapy and after drug treatment was stopped. In April 1996 his apolipoprotein A-I concentration was 0·25 giL (reference range 1·0--2·0), confirming the validity of the low HDL cholesterol result.
There have been several reports of markedly reduced HDL cholesterol concentrations following treatment with fib rate drugs.':" This appears to be a 'class' effect, occurring with bezafibrate and ciprofibrate (as in our case) and also with fenofibrate. In several of these cases, other side effects were noted with ciprofibrate therapy. An iatrogenic very low HDL cholesterol concentration is unlikely to be beneficial and we support the recommendation that patients who receive fibrate therapy should have regular measurements of
